Back to Search

Glecaprevir,Pibrentasvir – Uses, Dosage, and Brands in UAE

Brand Name: MAVIRET
Strength: 100 mg,40 mg | Form: Tablets
Price in UAE: AED 77349.50
Available in UAE pharmacies

About Glecaprevir,Pibrentasvir

Class: | Antiviral agent, Direct-acting antiviral (DAA) Use: | Treatment of chronic hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older, with or without compensated cirrhosis Adult dose: | 3 tablets (100 mg glecaprevir and 40 mg pibrentasvir) taken orally once daily with food Pediatric dose: | For patients aged 3 years and older, the dose is based on weight: weight 17 kg to < 30 kg: 2 tablets (50 mg glecaprevir and 20 mg pibrentasvir) once daily; weig

Drug Class

Antiviral agent, Direct-acting antiviral (DAA)

Uses & Indications

Treatment of chronic hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older, with or without compensated cirrhosis

Storage Requirements

Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light

Manufacturer & Packaging

Manufacturer: Abbvie Ltd., UNITED KINGDOM

Package Size

84s

Price & Supplier

Price in UAE: AED 77349.50

Dosage Information

Adult Dose

3 tablets (100 mg glecaprevir and 40 mg pibrentasvir) taken orally once daily with food

Pediatric Dose

For patients aged 3 years and older, the dose is based on weight: weight 17 kg to < 30 kg: 2 tablets (50 mg glecaprevir and 20 mg pibrentasvir) once daily; weight ≥ 30 kg: 3 tablets (100 mg glecaprevir and 40 mg pibrentasvir) once daily

Side Effects

Fatigue, headache, nausea, diarrhea, and elevated liver enzymes

Contraindications & Precautions

Co-administration with strong CYP3A inhibitors (e.g., rifampin, carbamazepine) or strong CYP3A inducers (e.g., St. John's Wort); hypersensitivity to any component of the formulation

Important Warnings

Risk of hepatitis B virus reactivation in patients with a history of HBV infection; monitor liver function during and after treatment; not recommended for use in patients with severe hepatic impairment (Child-Pugh Class C)

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Antiviral agent, Direct-acting antiviral (DAA) Medicines Browse All Categories